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Abstract: The interactions of nine amino acid derivatives of tert-butylquinone 
with biomacromolecules were studied. Sodium dodecyl sulphate (SDS) gel 
electrophoresis and mass spectrometry confirmed the absence of modifications 
of lysozyme by any of the synthesized compounds. Spectrophotometric studies 
demonstrated hyperchromism, i.e., the existence of interactions between the 
quinones and calf thymus DNA (CT-DNA). Determination of the binding cons-
tants by absorption titration indicated weak interactions between the quinone 
derivatives and CT-DNA. The quenching of fluorescence of the intercalator 
ethidium bromide (EB) from the EB–CT-DNA system and of the minor groove 
binder Hoechst 33258 (H) from the H–CT-DNA system by the synthesized 
derivatives indicated interactions of the compounds and CT-DNA. Circular 
dichroism (CD) spectra demonstrated a non-intercalative binding mode of the 
quinone derivatives to CT-DNA. Molecular docking results confirmed binding 
to the minor groove. The electrophoretic pattern showed no cleavage of the 
pUC19 plasmid in the presence of any of the synthesized compounds. The 
ability of the derivatives to scavenge radicals was confirmed by the 2,2-diphe-
nyl-1-picrylhydrazyl (DPPH) test. All the presented results suggest that the 
DNA minor groove binding is the principal mechanism of action of the exam-
ined amino acid derivatives. 
Keywords: quinone; DNA binding; minor groove; fluorescence. 
INTRODUCTION 
Understanding the mechanism of interactions of various anticancer drugs 
with biomacromolecules is a crucial aspect of drug discovery. Investigation of 
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the interactions of pharmacologically active quinones with biomacromolecules is 
a challenging task, because of their complex mechanism of action. Quinones are 
highly reactive compounds and the general mechanism of their action involves 
three processes: first, the redox couple quinone/hydroquinone can generate react-
ive oxygen species that damage biomacromolecules and inhibit electron transport 
in mitochondria and oxidative phosphorylation; second, quinones can be alkyl-
ated by cellular nucleophiles, such as proteins, enzymes and DNA molecules; 
third, compounds with a quinone moiety can non-covalently interact with DNA 
molecules.1–7 Most of the clinically useful quinone alkylating antitumor agents 
are active only after bioreductive activation. The term bioreductive activation 
includes a series of mechanisms of reduction of anticancer agents to reactive 
intermediates that can later undergo nucleophilic addition.8–11 In this way, some 
degree of selectivity is attained.  
In a previous study, besides very active avarone derivatives with amino 
acids, nine amino acid derivatives of the avarone mimic tert-butylquinone were 
synthesized.12 For the derivatisation, amino acids with non-polar aliphatic and 
aromatic residues including one D-amino acid, were selected. The derivatives 
showed moderate cytotoxic activity and a good selectivity on a panel of cancer 
cell lines. In this paper, the mode of action of the synthesized derivatives at the 
molecular level on linear and circular DNA, and a model protein were inves-
tigated. 
EXPERIMENTAL 
Materials and methods 
Lysozyme from hen egg white was obtained from Sigma–Aldrich, USA. An Eppendorf 
Mini Spin Plus centrifuge was used. Sodium dodecyl sulphate–polyacrylamide (SDS–PA) gel 
electrophoresis was performed using a Hoefer SE 600 Ruby vertical electrophoresis system. 
Mass spectra were recorded on a linear ion trap – Orbitrap hybrid mass spectrometer (LTQ 
OrbiTrap XL) with a heated electrospray ionization probe, HESI (Thermo Fisher Scientific, 
Bremen, Germany). UV–Vis spectra were collected on a Cintra 40 UV/Visible spectrometer. 
Fluorescence spectra were recorded using a Lumina fluorescence spectrometer (Thermo 
Fisher Scientific, Finland) equipped with a 150 W xenon lamp. The splits on the excitation 
and emission beams were fixed at 10 nm. Calf thymus DNA (CT-DNA) was purchased from 
Serva, Heidelberg. Agarose was obtained from Amersham Pharmacia-Biotech, Inc, USA. A 
HE 33 mini submarine electrophoresis unit (Hoefer, USA) with an EPS 300 power supply was 
used for the agarose gel electrophoresis. The stained gel was illuminated under a UV transillu-
minator (Vilber Lourmat, France) at 312 nm and photographed with a Nikon Coolpix P340 
digital camera through a Deep Yellow 15 filter, Tiffen, USA. The plasmid pUC19 was pur-
chased from Sigma–Aldrich, USA. A Thermo Scientific Appliskan (Thermo Fisher Scientific, 
Finland) was used for measuring absorbance at 517 nm for determining the DPPH scavenging 
activity.  
Details related to mass spectrometry, UV–Vis spectroscopic and fluorescence measure-
ments are given in Supplementary material to this paper. 
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Preparation of the quinones 
The amino acid derivatives of tert-butylquinone were synthesized as described pre-
viously.12 
Modification of lysozyme 
Modifications of lysozyme were performed in 20 % dimethyl sulfoxide (DMSO), 20 % 
methanol and distilled water, respectively. The quinones were dissolved in 240 μL of DMSO, 
methanol and water, respectively (final concentration 2 mg mL-1) and lysozyme was dissolved 
in 960 μL of water (final concentration 5 mg mL-1). The reaction mixtures contained 50 mM 
NaHCO3 and the pH value of the mixture was 8.5. The reaction was performed at r.t. with 
stirring for 48 h. During the reaction, the formation of a precipitate was observed when 
DMSO and methanol were used. The precipitate did not contain free quinones. The mixture 
was centrifuged at 14000 rpm and the supernatant was desalted by dialysis against distilled 
water. Concerning the precipitate, three volumes of water were added and after centrifugation, 
the resulting solution was dialysed against distilled water. 
Modifications of lysozyme were also performed by the same procedure without 
NaHCO3, in aqueous buffer solutions (100 mM phosphate buffer pH 7.4, 100 mM acetate 
buffer pH 4.5 or 100 mM ammonia buffer pH 10). Under these conditions, no precipitate was 
formed. 
The formation of a possible conjugate was checked using SDS electrophoresis and mass 
spectrometry. 
SDS PA gel electrophoresis 
SDS polyacrylamide gels were made by a standard procedure.13 The concentration of the 
running gel was 10 % and of the stacking gel, 4 %. Each sample (25 μL) was applied to the 
gel. The voltage was held constant (80 V) until the samples entered the running gel. For 
separation through the running gel, the voltage was raised to 150 V. 
DNA binding experiments 
All buffer solutions were prepared in deionised water and filtered through 0.2 μm filters, 
Nalgene, USA. Stock solutions of the tested compounds were prepared in DMSO at a concen-
tration of 10 mM. Calf thymus DNA (CT-DNA, lyophilized, highly polymerized, purchased 
from Serva, Heidelberg, Germany) was dissolved in Tris buffer (20 mM Tris–HCl, pH 7.5) 
overnight at 4 °C. This solution was stored at the same temperature and was stable for several 
days. The ratio of the UV absorbance at 260 and 280 nm (A260/A280 of 1.94) indicated that the 
aqueous solution of CT-DNA was sufficiently free of protein. The concentration of CT-DNA 
(3.12 mg mL-1) was determined from the UV absorbance at 260 nm using an extinction 
coefficient ε260 = 6600 M-1 cm-1.14 
CD studies 
The CD spectra of CT-DNA (0.5 mM) alone and with two concentrations of the deri-
vatives (0.25 and 0.50 mM) were recorded using a Jasco J-815 circular dichroism spectro-
meter. The temperature of the sample was kept constant at 25 °C. All CD spectra were 
recorded in the range from 220 to 310 nm at a scan speed of 200 nm min-1 with a spectral 
bandwidth of 0.1 nm. The average of three scans was taken in all the experiments. The 
background spectrum of the bicarbonate solution (40 mM, pH 8.4) was subtracted from the 
spectra of DNA and DNA‒derivative complexes. 
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DNA cleavage experiments 
The plasmid pUC19 (2686 bp) used for the DNA cleavage experiments was prepared by 
its transformation in chemically competent cells of Escherichia coli strain XL1 blue. Amp-
lification of the clone was realised according to the protocol for growing E. coli culture over-
night in LB medium at 37 °C.15 Purification was performed using Qiagen Plasmid plus Maxi 
kit. DNA was eluted in 10 mM Tris–HCl buffer (pH 7.9) and stored at –20 °C. The con-
centration of plasmid DNA (460 ng μL-1) was determined by measuring the absorbance of the 
DNA-containing solution at 260 nm. One optical unit corresponds to 50 μg mL-1 of double- 
-stranded DNA. 
The cleavage reaction of supercoiled pUC19 by the different compounds (final concen-
tration 1 mM) was investigated by incubation of 460 ng of plasmid in a 20 μL reaction 
mixture in 40 mM bicarbonate solution (pH 8.4) at 37 °C for 90 min. The reaction mixture 
was vortexed from time to time. The reaction was terminated by short centrifugation at 10000 
rpm and the addition of 5 μL of loading buffer consisting of 0.25 % bromophenol blue, 0.25 
% xylene cyanol FF and 30 % glycerol in TAE buffer (40 mM Tris–acetate, 1 mM EDTA, pH 
8.24).  
The samples (20 μL) were analysed by electrophoresis on 1 % agarose gel prepared in 
TAE buffer, pH 8.24. The electrophoresis was performed at a constant voltage (80 V) until the 
bromophenol blue had passed through 75 % of the gel. After electrophoresis, the gel was 
stained for 30 min by soaking it in an aqueous ethidium bromide solution (0.5 μg mL-1).  
Molecular docking   
For DNA docking simulations, the crystal structure of dodecamer 
d(CGCGAATTCGCG)2, PDB ID: 3U2N,16 was obtained from the Protein Data Bank 
(http://www.rcsb.org/pdb). All water molecules and ions, as well as ligands were removed 
using Autodock Tools 1.5.6.17,18 
Quinone molecules were prepared using Maestro 10.4 from the Schrodinger Suite 2015- 
-4.19 All possible tautomer structures at pH 7.00±2.00 were generated using Epik 3.4 from the 
Schrodinger Suite 2015-420 and their charges were determined in Jaguar 9.021 using the HF/6- 
-31g* method. These charges were used further in docking simulations. The docking simul-
ations were realised in Autodock Vina 1.1.2.22 The grid box size was set to 25×28×45 Å3 and 
exhaustiveness to 500. Discovery Studio Visualizer 4.5 was used for visualization of the 
interactions.23 
DPPH radical scavenging activity 
Details of the DPPH radical scavenging activity test are given in the Supplementary 
material. 
RESULTS AND DISCUSSION  
The amino acid derivatives of tert-butylquinone (Scheme 1) were obtained 
by nucleophilic addition of an amino acid to the quinone, as previously des-
cribed.12  
For investigation of the interactions of quinones with proteins, lysozyme was 
chosen in a previous study as the enzyme model, since the amino groups of 
lysine in lysozyme were shown to react by Michael addition with the quinone 
moiety of similar quinones, including alkylamino derivatives.24 The modification 
reaction was monitored by SDS electrophoresis and mass spectrometry. The 
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results on the SDS electrophoregram (Fig. 1) showed that the synthesized amino 
acid derivatives did not modify lysozyme. Modification of lysozyme was not 
observed under any of the applied conditions. 
     
Scheme 1. Structures of the investigated compounds. 
 
Fig. 1. SDS–PAGE of lysozyme (Lys) and modifications of Lys with derivatives 1a–i 
in 20 % DMSO. 
In the mass spectra obtained for both the supernatants and precipitates only 
the peak of unmodified lysozyme at m/z = 14305 (e.g. 1431.499 for z = 10) was 
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observed. The obtained results showed that synthesized derivatives of tert-butyl-
quinone did not modify lysozyme (Fig. S-1 of the Supplementary material to this 
paper). Explanation for this behaviour is the steric bulk of tert-butylquinone, as 
well as the rapid establishment of tautomeric equilibrium, and consequently, the 
absence of the stable quinone structure12 that is necessary for attack of protein 
nucleophiles.24–26 It could be concluded that these compounds cannot be alkyl-
ated by the nucleophilic groups of the model protein. 
DNA is one of the principal targets of many different classes of drugs that 
are in clinical use, from anticancer and antiviral drugs to antibiotics. There are 
two main types of interactions between DNA and low molecular weight mole-
cules, covalent and non-covalent interactions. Due to the rapid interconversion of 
the tautomeric forms and the assumed difficulty of formation of covalent bonds 
between the derivatives and biomacromolecules, as evidenced with lysozyme, 
which contains several highly nucleophilic lysine residues, the focus of this work 
was on the three most important non-covalent modes of drug–DNA binding: 
intercalation, groove binding and external binding. 
UV–Visible absorption spectroscopy is one of the simplest, most common 
techniques for studying the stability of DNA and its interactions with small mole-
cules. When a small molecule interacts with DNA, a complex is formed, with 
changes in the absorbance and/or the positions of peaks.  
Representative UV absorption spectra of derivative 1h at different concen-
trations, both in the absence and presence of a fixed concentration of CT-DNA, 
are shown in Fig. 2.  
 
Fig. 2. UV–Vis absorption spectra of different concentrations (50, 100 and 200 µM, from 
bottom to top) of 1h before and after interaction with CT-DNA. 
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In the absence of DNA, the absorption spectra of the derivatives showed 
absorbance maxima in the range of 276–283 nm. Hyperchromism was observed 
upon addition of DNA. These results indicated an interaction between the deri-
vatives and DNA molecules. In comparison with the spectrum of CT-DNA, in all 
absorption spectra, (the exception is the proline derivative 1f), a bathochromic 
shift was noted. As small red shifts were followed by hyperchromism with all 
derivatives (Table I), it could be concluded that the examined amino acid deri-
vatives bind to the double-stranded CT-DNA through non-covalent interact-
ions,27 probably by groove binding and/or electrostatic interactions rather than 
intercalation. 
TABLE I. Hyperchromism induced by the synthesized derivatives 1a–i in 50 µM solution. 
The induction in % was calculated using expression DNA+D DNA D DNA+D100( ) /A A A A− − , 
where ADNA, AD and ADNA+D refer to the absorbance of DNA, derivatives in 50 µM solution 
and complex DNA–derivative, respectively, at 260 nm 
Compound 1a 1b 1c 1d 1e 1f 1g 1h 1i 
% 26.71 8.55 5.18 8.04 1.12 27.68 16.37 2.20 7.03 
In order to obtain information on the stability of the derivative/CT-DNA 
complex, spectroscopic titrations of solutions of CT-DNA were performed (the 
results are given in Fig. S-2 of the Supplementary material). The obtained values 
of binding constants (Table S-I of the Supplementary material) are notably lower 
than those reported for intercalators, which indicates non-intercalative binding 
interactions between the quinone derivatives and CT-DNA.28 
Various well-known DNA binding dyes are used to establish the type of 
drug–DNA interactions. Ethidium bromide is extensively used as a fluorescence 
probe that binds to DNA in an intercalative fashion. In case of groove binders, 
competitive displacement studies are done using a Hoechst dye that binds to the 
minor groove of double-stranded B-DNA and is highly specific for AT-rich 
sequences.  
In order to investigate further the binding mode of tert-butylquinone derivat-
ives to CT-DNA, fluorescence analyses were performed with ethidium bromide 
(EB) and Hoechst 33258 (H). The results of the competitive fluorescence study 
of the representative derivative 1h with the intercalator EB are given in Fig. 3. 
The fluorescence intensity of the band at 600 nm of the EB–CT-DNA sys-
tem decreased significantly with the increasing concentration of all the quinone 
compounds (Table II). The greatest decreases in the fluorescence intensity were 
observed for the alanine (1b), D-valine (1d), phenylalanine (1h) and tryptophan 
(1i) derivatives at the highest used concentrations. The fluorescence emission 
spectrum for the proline derivative 1f revealed the smallest reduction in the fluor-
escence intensity, which is consistent with a previous study on the effect of pro-
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line in displacing DNA-bound ethidium bromide, in which fluorescence emission 
data of proline revealed a marginal displacement in contrast to other amino acids.29 
 
Fig. 3. Displacement of ethidium bromide bound to CT-DNA by derivative 1h: emission 
spectra of EB alone (bottom line), EB bound to CT-DNA (top line) and quenching of 
EB–CT-DNA system by derivative 1h at increasing concentrations (50, 100 and 200 µM 
solutions, from top to bottom). 
TABLE II. The decrease of fluorescence of EB–CT-DNA complex upon addition of 1a–i (200 
µM solution). The decrease in % was calculated using the expression 
FDNA+EB FDNA+EB+D FEB FDNA+EB100( ) /− −I I I I , where IFDNA+EB, IFDNA+EB+D and IFEB refer to 
the fluorescence intensity of complex EB–DNA, EB–DNA–derivatives and EB, respectively, 
at 600 nm 
Compound 1a 1b 1c 1d 1e 1f 1g 1h 1i 
% 21.80 23.87 17.85 29.86 19.74 6.59 20.29 26.79 22.64 
According to the results and structural differences between the most active 
derivatives, it could be concluded that the derivatives did interact with DNA, 
which led to a decrease in fluorescence intensity, but the results could hardly be 
considered evidence of their intercalation, especially in view of the UV spectral 
data that showed hyperchromism and not hypochromism. It is known from the 
literature that an indirect displacement can occur whereby the compounds induce 
structural changes in DNA and hence reduce the binding affinity for EB.30 
Binding of Hoechst 33258 to CT-DNA was followed by excitation at 350 
nm with the maximum in fluorescence at 444 nm. The fluorescence intensity at 
444 nm of the H–CT-DNA complex decreased with increasing concentration of 
most of the quinone compounds (Fig. 4, Table III). These results suggest minor 
groove binding of the amino acid derivatives. It seems that minor groove binding 
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might be of importance for their action on tumour cells since the three com-
pounds that do not displace H from the complex are among the least active 
derivatives (IC50 never below 30 μM for any tested cell line). These exceptions 
were 1a, 1e and 1f, which induced an increase in the fluorescence of the 
H–CT-DNA complex. A possible explanation for the increase in fluorescence is 
the formation of a ternary complex CT-DNA–dye–quinone. Such behaviour was 
shown in literature31 for argininamide with an oligonucleotide aptamer. This 
external binding of 1a and 1f induced a high hyperchromism in the UV–Vis 
spectra, while binding of leucine derivative 1e was weak because of its bulky 
isobutyl group. 
 
Fig. 4. Displacement of Hoechst 33258 bound to CT-DNA by derivative 1h: emission spectra 
of Hoechst 33258 alone (bottom line), H bound to CT-DNA (top line) and quenching of H–
CT-DNA system by derivative 1h at increasing concentrations (50, 100 and 200 µM, 
from top to bottom). 
TABLE III. Decrease in the fluorescence of the H–CT-DNA complex upon addition of 1a–i 
(200 µM solution). The decrease was calculated using the expression 
FDNA+H FDNA+H+D FH FDNA+H100( ) /− −I I I I , where IFDNA+H, IFDNA+H+D and IFH refer to the flu-
orescence intensity of complex H–DNA, H–DNA–derivatives and H, respectively, at 444 nm 
Compound 1a 1b 1c 1d 1e 1f 1g 1h 1i 
% –25.55 19.52 53.83 23.76 –5.50 –37.92 31.16 30.44 33.89 
CD spectroscopy is very sensitive to the changes in the secondary structure 
of biomacromolecules and, therefore, is widely used for detection of changes in 
secondary structure of DNA upon interactions with small molecules,32 and non- 
-covalent DNA–drug interactions resulting in altered CD spectral properties.33,34 
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The CD spectrum of CT-DNA displays a positive band around 275 nm due to 
base stacking and a negative band around 245 nm due to the right-handed helicity 
of the B-DNA form.35 Intercalation significantly changes the intensities of both 
the bands, stabilizing the right-handed B conformation of DNA, while groove 
binding and electrostatic interactions of small molecules show low or no dis-
turbances.36 As shown in a representative CD spectrum of 1h (Fig. 5), after its 
addition to CT-DNA, there were no significant changes in the CD spectrum. 
These results provide evidence that the derivatives do not bind to CT-DNA by 
intercalation, but rather via groove binding. 
 
Fig. 5. Effect of 1h on CD spectra of CT-DNA. CD spectra of CT-DNA (0.50 mM) in 
bicarbonate solution (40 mM, pH 8.4) with varying concentrations of 1h. Each spectrum was 
obtained at 25 °C with 1 mm path length cell. 
For the support of the evidence for minor groove binding, molecular docking 
was performed with the DNA sequence d(CGCGAATTCGCG)2, PDB ID: 
3U2N.16 The calculations suggested binding to the minor groove. No inter-
calating structures were found. The pattern of binding is presented in Fig. 6. The 
established interactions between molecules and DNA nucleotides are predomi-
nantly hydrogen bonds and some carbon–hydrogen bonding and π–alkyl inter-
actions. 
Based on the previous results in which it was shown that several types of ava-
rone derivatives cleaved plasmid DNA,37 the capability of the synthesized deri-
vatives to cleave pUC19 plasmid was examined using electrophoretic analysis. 
DMSO did not show any effect on plasmid DNA under the applied experimental 
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conditions. Electrophoretic pattern showed that there was no cleavage of pUC19 
with any of the synthesized compounds under the applied conditions (Fig. 7). 
Fig. 6. Binding of compound 1h to the minor 
groove. 
 
Fig. 7. Agarose gel electrophoretic analysis of plasmid pUC19 without (P) and with 
derivatives 1a–i (1 mM). 
These results differed from previous results with quinone compounds,37 
which showed a significant cleavage of plasmid DNA. The cleavage of DNA 
molecules by quinones in vitro could be explained by the presence of ROS, 
which leads to single-strand and/or double-strand breaks of the plasmid chain. 
Quinones have the ability to generate oxygen radicals through semiquinone inter-
mediates formed either after nucleophilic attack on the quinone moiety or after 
reduction and subsequent reoxidation of hydroquinone or semiquinone into qui-
none. As the investigated amino acid derivatives interchange rapidly between 
tautomers and are not susceptible to nucleophilic attack and since the experi-
mental conditions were not reducing, the lack of cleavage could be expected. 
Considering the observation that the derivatives do not generate radicals in 
vitro, their ability to scavenge radicals was investigated by the DPPH test. The 
results of scavenging activity of amino acid derivatives of tert-butylquinone are 
listed in Table IV. All the derivatives showed some antioxidant activity, although 
weaker than ascorbic acid. The activity could be ascribed to the amino acid moi-
ety. Amino acids were shown to react with DPPH radical by two mechanisms, 
namely oxidative decarboxylation, initiated by abstraction of hydrogen from the 
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carboxylic group and oxidative deamination, initiated by hydrogen abstraction 
from the NH group.38 Based on the results presented here, which showed that the 
proline derivative 1f was the most active compound, and that there are no other 
clear-cut structure‒activity relationships, oxidative decarboxylation is the prin-
cipal reaction pathway of this series of compounds. 
TABLE IV. Antioxidant activity (IC50 / mM) of compounds 1a–i 
Compound 1a 1b 1c 1d 1e 1f 1g 1h 1i Ascorbic acid 
IC50 1.57 2.87 1.25 8.89 1.27 0.34 1.37 1.02 2.37 0.07 
CONCLUSION 
In this paper, the mode of biological action of amino acid derivatives of tert- 
-butylquinone was investigated at the molecular level. It was observed that the 
synthesized derivatives, because of the nature of their substituents, have an atyp-
ical mode of action for quinones. Neither addition of nucleophilic groups of pro-
teins nor DNA strand nicking was observed. It could be concluded that the pre-
ferential mechanism of action of the investigated series of biologically active 
compounds with the quinone moiety, the structural elements of which allowed 
rapid interconversion of tautomeric forms, is a non-covalent interaction with 
DNA molecules, namely minor groove binding. This mechanism of action, with 
less diverse effects at the molecular level, probably leads to the observed low 
toxicity of these compounds to the tested normal cell line,12 making them a pro-
mising lead for further anticancer drugs. 
SUPPLEMENTARY MATERIAL  
Additional experimental details and mass spectra of the unmodified lysozyme and 
lysozyme after treatment with 1h are available electronically at the pages of journal website: 
http://www.shd.org.rs/JSCS/, or from the corresponding authors on request. 
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И З В О Д  
ИНТЕРАКЦИЈЕ ЦИТОТОКСИЧНИХ АМИНОКИСЕЛИНСКИХ ДЕРИВАТА 
tert-БУТИЛХИНОНА СА DNA И ЛИЗОЗИМОМ 
ЈОВАНА П. ВИЛИПИЋ1, ИРЕНА Т. НОВАКОВИЋ2, МАРИО В. ЗЛАТОВИЋ3, МИРОСЛАВА Т. ВУЈЧИЋ2, 
СРЂАН Ј. ТУФЕГЏИЋ2 И ДУШАН М. СЛАДИЋ3 
1Иновациони центар Хемијског факултета, Универзитет у Београду, Студентски трг 12–16, 
Београд, 2Институт за хемију, технологију и металургију, Центар за хемију, Универзитет у 
Београду, Његошева 12, Београд и 3Хемијски факултет, Универзитет у Београду, 
Студентски трг 12–16, Београд 
Испитане су интеракције девет аминокиселинских деривата tert-бутилхинона са 
биомакромолекулима. SDS гел-електрофорезом и масеном спектрометријом потврђено 
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је одсуство модификација лизозима било којим од синтетисаних једињења. Спектро-
фотометријска испитивања су показала појаву хиперхромизма, као последицу постојања 
интеракција између хинона и CT-DNA. Константе везивања одређене апсорпционом тит-
рацијом указују на слабе интеракције између хинонских деривата и CT-DNA. Синтети-
сани деривати смањују интензитет флуоресценције етидијум-бромида и боје Hoechst 
33258 у комплексу са DNA, што потврђује постојање интеракција са DNA из тимуса 
говечета (CT-DNA). CD спектри указују на изостанак интеркалације хинона у исту. 
Резултати молекулског моделовања потврђују везивање деривата у малу бразду. Елек-
трофоретска испитивања су показала да није дошло до цепања плазмида pUC19 у при-
суству било ког испитиваног деривата. Способност деривата да хватају слободне ради-
кале потврђена је DPPH тестом. Сви приказани резултати указују на то да је механизам 
дејства аминокиселинских деривата везивање у малу бразду. 
(Примљено 25. јула, ревидирано 10. новембра, прихваћено 14. новембра 2016) 
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